Sartorius Shares Rise on Signs of Order Recovery in 3Q
2023年10月19日 - 6:30PM
Dow Jones News
By Giulia Petroni
Shares in Sartorius rose on Thursday after the German
life-sciences group said there were signs of a slight recovery in
order intake at the end of the third quarter despite soft
demand.
At 0852 GMT, the stock traded 7.1% higher at EUR272.30.
"We expect orders to continue to increase slightly in the fourth
quarter, especially in the bioprocess solutions division, and
anticipate profitable growth in 2024 and beyond," Chief Executive
Joachim Kreuzburg said.
According to Citi analysts, the third-quarter order intake at
the bioprocess unit increased 15% on quarter, pointing to an
encouraging book-to-bill improvement.
The lab products division instead continued to show weakness,
partly due to increased reluctance from customers from China and
the U.S. to purchase laboratory instruments, according to the
company.
Sartorius downgraded its full-year targets on lower nine-month
sales and earnings earlier this month.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
October 19, 2023 05:15 ET (09:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Sartorius (TG:SRT)
過去 株価チャート
から 4 2024 まで 5 2024
Sartorius (TG:SRT)
過去 株価チャート
から 5 2023 まで 5 2024
